Trial intelligence / Profile preview

Femoral nerve block with levobupivacaine for pain control in older adults with proximal femoral fracture

2015-004119-19Phase 4Active

Sponsor
Reinier de Graaf Hospital
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hip fracture comparing Chirocaine femoral nerve block with Placebo injection (2 arms). Primary endpoint: Raw pain intensity difference up to 4 hours after femoral nerve blockage. Started Feb 2016; status: active.

02

Drugs

levobupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on 2015-004119-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004119-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call